Deferred revenue adjustment reflects the fair value adjustment to deferred revenues acquired in connection with the Merger. The fair value of deferred revenue represents an amount equivalent to the estimated cost plus an appropriate profit margin, to perform services related to legacy Allscripts software and product support, which assumes a legal obligation to do so, based on the deferred revenue balances as of October 10, Tax Rate Alignment.
Purchase accounting adjustments made in accordance with GAAP can make it difficult to make meaningful comparisons of the underlying operations of the business without considering the non-GAAP adjustments that we have provided and discussed herein. Investors and potential investors are encouraged to review the reconciliation of non-GAAP financial measures with GAAP financial measures contained within the attached condensed consolidated financial statements.
Allscripts uses innovation technology to bring health to healthcare. More than , physicians, hospitals and nearly 10, post-acute and homecare organizations utilize Allscripts to improve the health of their patients and their bottom line. Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and performance management software, clinical content and professional services that help healthcare organizations improve clinical, financial and operational outcomes.
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. This communication is being made in respect of the proposed merger transaction involving Allscripts-Misys Healthcare Solutions, Inc. Allscripts and its directors and executive officers and other persons may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction.
Investors and stockholders can obtain free copies of these documents from Allscripts and Eclipsys using the information above. This communication contains forward-looking statements within the meaning of the federal securities laws.
These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Allscripts, Eclipsys or the combined company or the proposed transaction.
The statements herein speak only as of their date and neither Allscripts nor Eclipsys undertakes any duty to update any forward-looking statement whether as a result of new information, future events or changes in their respective expectations. Frank Allscripts. Stein Allscripts. Cigarran Eclipsys. Wrinn Eclipsys.
Contact us. Open menu. About Allscripts Allscripts uses innovation technology to bring health to healthcare. About Eclipsys Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and performance management software, clinical content and professional services that help healthcare organizations improve clinical, financial and operational outcomes.
Important Information for Investors and Stockholders This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. Forward-Looking Statements This communication contains forward-looking statements within the meaning of the federal securities laws. Contact Allscripts. Schedule An Allscripts Demo. This enables them to more-effectively monitor a patient's condition, order tests, view test results, and have a comprehensive view of the patient's treatment history.
The system's embedded clinical content and evidence-based rules help prevent potential medical errors and help ensure that best-practice medicine is being provided.
HSS has also selected the Eclipsys Consulting Group for performance improvement services to be provided during the software implementation phase. These services will help ensure that HSS achieves process improvement and clinician adoption and a rapid return on investment. Ruflin, Eclipsys president and CEO. Its insights will be invaluable as we continue to expand the evidence-based medical content of our Sunrise solutions.
The Fund shall have the following responsibilities in connection with Installation and Conversion of the System:. Installation Where installation is required, Contractor shall be responsible for placing and installing the product in the required locations at no additional charge, unless otherwise designated on the Contract or purchase order.
All materials used in the installation shall be of good quality and shall be free of defects that would diminish the appearance of the product or render it structurally or operationally unsound.
Installation includes the furnishing of any equipment, rigging, and materials required to install or replace the product in the proper location. Contractor shall protect the site from damage and shall repair damages or injury caused during installation by Contractor or its employees or agents. If any alteration, dismantling, excavation, etc.
Contractor shall perform installation work so as to cause the least inconvenience and interference with Customers and with proper consideration of others on site.
0コメント